Why is the Hemato-Oncology Market Complex for Market Researchers?

February 27, 2019 | AplusA

The hematology oncology market is one of the most rapidly developing, with over sixty oncology drugs having been approved by the FDA in the last five years. Advances in targeted therapies,...

Read More


Chronic Lymphocytic Leukemia: Current and Future CLL Treatments

January 24, 2019 | AplusA

Chronic Lymphocytic Leukemia is the most common form of leukemia in Western countries. Although currently incurable, there have been significant advances in research efforts of CLL treatments in...

Read More

Therapeutic Areas hemato-oncology

Blood Cancer Treatments: Current and Future

December 11, 2018 | AplusA

Despite being considered as rare diseases, blood cancers account for 8% of all cancers and mainly affect children, young adults and the elderly. Each of the three main families of hematological...

Read More

AplusA News

AplusA / Ifop Group Acquires Sociovision

July 5, 2018 | AplusA

To “master a changing world”, Sociovision developed a unique expertise in the monitoring of cultural and lifestyle changes across the globe. By integrating Sociovision we will further enhance the...

Read More

Patients Products and Services Digital

New AplusA Digital Case study: PSP

March 14, 2018 | AplusA

Market Research Industry

The Most Popular Jobs for Millennials. Market research analyst in the Top 10.

February 26, 2018 | Derek Miller, CEPF®

The first cohort of millennials entered the workforce around the time of the Great Recession, when the economy was sputtering. Combine that fact with the constantly changing make-up of the modern...

Read More

AplusA News

AplusA and Bell Falla merge forces in the US

June 29, 2016 | AplusA

AplusA and Bell Falla merge forces in the US to become a leading market research agency dedicated to the healthcare industry.AplusA is pleased to announce that Bell Falla and Associates has...

Read More
1 2 3 4